News
News

The latest updates from AFAR.

Grantee in the News: Reisa Sperling in the Washington Post on early biomarkers of Alzheimer’s disease

Jun 22
2018

Grantee in the News: Reisa Sperling in the Washington Post on early biomarkers of Alzheimer’s disease View MoreBACK

On June 15, 2018, The Washington Post highlighted 2003 Beeson Scholar Reisa Sperling, M.D. M.M.Sc.

Five myths about Alzheimer’s disease” highlights Dr. Sperling’s research  with the Harvard Aging Brain Study on “the slow transition from a healthy brain to Alzheimer’s by studying the same normal middle-aged and older adults for years.”

The overall goal of the Harvard Aging Brain Study is to elucidate the earliest changes in molecular, functional and structural imaging markers that signal the transition from normal cognition to progressive cognitive decline along the trajectory of preclinical Alzheimer's Disease.

Read the full article here and learn more about the Harvard Aging Brain Study here.


Reisa Sperling, MD, M.M.Sc., is the Director of the Center for Alzheimer's Research and Treatment and Co-Director of the Neuroimaging Core at the Massachusetts Alzheimer's Disease Research Center, and a Professor of Neurology at Harvard Medical School.





View MoreBACK TO TOP